- ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions
- ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference
- Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study
- ResMed Announces Leadership Change
- ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022
- ResMed Announces Participation in the 24th Annual Macquarie Australia Conference
- ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022
- ResMed Announces Participation in the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
- ResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day
- ResMed Announces Participation in the Oppenheimer 32nd Annual Healthcare Conference
More ▼
Key statistics
On Friday, Resmed Inc (RMD:NYQ) closed at 211.50, 11.67% above the 52 week low of 189.40 set on May 12, 2022.
52-week range
Markit short selling activity
Open | 210.85 |
---|---|
High | 211.58 |
Low | 208.20 |
Bid | 0.00 |
Offer | 270.02 |
Previous close | 207.49 |
Average volume | 765.25k |
---|---|
Shares outstanding | 146.28m |
Free float | 145.10m |
P/E (TTM) | 39.85 |
Market cap | 30.94bn USD |
EPS (TTM) | 5.31 USD |
Annual div (ADY) | 1.68 USD |
---|---|
Annual div yield (ADY) | 0.79% |
Div ex-date | May 11 2022 |
Div pay-date | Jun 16 2022 |
Data delayed at least 15 minutes, as of Jun 24 2022 21:10 BST.
More ▼